PM20D1 function in Alzheimer's disease

Project coordinator : Dr. Jose Sanchez-Mut

Institution:  EPFL 

Funding mechanism:  Principal Investigator Grant

Project:  PM20D1 function in Alzheimer's disease

Funding status:  Completed

Grant amount (CHF): 200'000

More details

Role of astrocytic mitochondria in the early stages of Alzheimer disease

Project coordinator : Dr. Kevin Richetin

Institution:  Centre Leenaards de la Mémoire - CHUV 

Funding mechanism:  Career Development Award

Project:  Role of astrocytic mitochondria in the early stages of Alzheimer disease

Funding status:  Completed

Grant amount (CHF): 295'000

[ '', 46.19524, 9.025768, '1 project', 'CHF 298'662', '23' ], [ '', 46.519098, 6.631094, '3 projects', 'CHF 894'104', '22' ], [ '', -27.468106, 153.022617, '1 project', 'CHF 200'000', '21' ], [ '', 46.193456, 6.149027, '1 project', 'CHF 275'000', '20' ], [ '', 47.567776, 7.603521, '2 projects', 'CHF 399'908', '19' ], [ '', 47.352912, 8.570472, '1 project', 'CHF 275'300', '18' ], [ '', 47.53876, 8.229726, '1 project', 'CHF 292'084', '17' ], [ '', 46.949651, 7.425741, '1 project', 'CHF 300'000', '16' ], [ '', -5.041016, -42.766699, '1 project', 'CHF 100'000', '15' ], [ '', 38.344358, -0.492095, '1 project', 'CHF 100'000', '14' ], [ '', 37.776072, -122.414948, '1 project', 'CHF 200'000', '13' ], [ '', 46.521821, 6.5723, '3 projects', 'CHF 683'422', '12' ], [ '', 46.950309, 7.438267, '1 project', 'CHF 298'553', '11' ], [ '', 46.947884, 7.426528, '2 projects', 'CHF 498'553', '10' ], [ '', 46.947443, 7.424627, '1 project', 'CHF 298'553', '9' ], [ '', 47.376819, 8.549135, '5 projects', 'CHF 1'400'000', '8' ], [ '', 47.374053, 8.551346, '11 projects', 'CHF 2'943'081', '7' ], [ '', 46.522603, 6.58, '5 projects', 'CHF 1'369'101', '6' ], [ '', 47.376415, 8.547616, '11 projects', 'CHF 2'580'639', '5' ], [ '', 47.560886, 7.582576, '7 projects', 'CHF 1'306'606', '1' ], ]; var string = 'this is new string'; var locationtext = []; locationtext = [ [ 'CHF 200'000', 'PM20D1 function in Alzheimer's disease', '', ], [ 'CHF 295'000', 'Role of astrocytic mitochondria in the early stages of Alzheimer disease', '', ], [ 'CHF 294'541', 'The factor XII-driven contact system as a new therapeutic target in Alzheimer's disease', '', ], [ 'CHF 294'541', 'Imaging corticostriatal loop dysfunction during skilled locomotion of Parkinsonian mice', '', ], [ 'CHF 200'000', 'How glial metabolic support impacts Alzheimer’s disease pathophysiology', '', ], [ 'CHF 300'000', 'Mechanistic insights into development of prion induced spongiform phenotype and neurotoxicity', '', ], [ 'CHF 300'000', 'Impaired immune surveillance in Alzheimer's disease: studies on pre-clinical transgenic models and patient-derived samples', '', ], [ 'CHF 299'999', 'The Structure of Prionoid Tau Strains', '', ], [ 'CHF 300'000', 'Elucidating the pathogenic mechanism of small vessel calcification in idiopathic basal ganglia calcification', '', ], [ 'CHF 299'104', 'Emotion dysregulation in Alzheimer's patients: a new model based on patients with neurodegenerative loss of the amygdala and hormonal regulation related to personality', '', ], [ 'CHF 227'500', 'Impact of lymphatic outflow in the brain during aging and neurodegenerative disorders', '', ], [ 'CHF 298'662', 'Nuclear Tau in Health and Disease', '', ], [ 'CHF 290'199', 'Targeted reverse chemical genetics approach to study the role of CREBBP/p300 in Alzheimer’s disease', '', ], [ 'CHF 200'000', 'A novel approach to study the progression of neurodegenerative diseases: investigating the young brain to understand the old', '', ], [ 'CHF 300'000', 'New ocular biomarkers for early detection of Alzheimer's disease', '', ], [ 'CHF 197'728', 'Using uncoupling in mitochondria of astrocytes to promote neuroprotection in Alzheimer's disease', '', ], [ 'CHF 283'422', 'Traces towards dementia: Identifying neuronal subpopulations and pathogenic mechanisms at presymptomatic stages of Alzheimer´s disease in a new mouse model', '', ], [ 'CHF 200'000', 'The role of the endoplasmic reticulum-mitochondria coupling in Taurelated neurodegenerative diseases', '', ], [ 'CHF 200'000', 'Novel anti-PrP human antibodies for therapy of prion diseases', '', ], [ 'CHF 200'000', 'Non-invasive multi-modal imaging of the temporal and spatial relations of amyloid-beta, tau pathology, brain connectivity and atrophy in murine Alzheimer`s disease models', '', ], [ 'CHF 200'000', 'Single-molecule live-cell imaging of repeat-containing RNAs and proteins in C9orf72-associated FTD/ALS', '', ], [ 'CHF 295'607', 'Mechanism of the TDP-43 p53 axis in inducing neuronal death in Frontotemporal Lobular Degeneration', '', ], [ 'CHF 212'599', 'Highly sensitive microfluidic assays for quantification of soluble oligomers and diagnostic biomarkers in Alzheimer’s disease', '', ], [ 'CHF 275'000', 'Discovering complex connections between brain energy metabolism and Alzheimer disease: Metabolomics-led system’s wide clinical and experimental study', '', ], [ 'CHF 274'400', 'Mechanisms that govern maturation and disassembly of stress granules', '', ], [ 'CHF 272'269', 'Purchase of Light Sheet Microscope', '', ], [ 'CHF 199'908', 'The Neuronal Basis of Anxiety in Parkinson’s Disease: Investigating the Impact of Dopaminergic Degeneration on Amygdala Circuits', '', ], [ 'CHF 200'000', 'Biophysical Re-organization of Neuronal Cytosol as a Trigger for Protein Aggregation in Polyglutamine Expansion Disorders', '', ], [ 'CHF 275'300', 'Dynamics of brain iron burden and APOE4 related hippocampal atrophy', '', ], [ 'CHF 300'000', 'Exploring trans-synaptic mechanisms of mutant huntingtin spreading', '', ], [ 'CHF 292'084', 'Mechanisms of adhesion GPCR signalling in sustaining neuronal tissue: implications for physiology and pathology', '', ], [ 'CHF 300'000', 'Exploring neuroprotective role of enhanced slow-wave sleep in rodent models of protein aggregation disorders', '', ], [ 'CHF 300'000', 'Improving slow wave sleep to enhance memory consolidation and new learning in individuals at risk for dementia', '', ], [ 'CHF 300'000', 'Investigating the role of astrocyte signaling in the synaptic, network, and cognitive derangement in Alzheimer's disease with innovative imaging and genetic approaches', '', ], [ 'CHF 100'000', 'NAAA targets and therapeutic mechanisms in Alzheimer’s disease', '', ], [ 'CHF 200'000', 'Adaptive gamified Body-Brain Training for patients with early Alzheimer’s disease', '', ], [ 'CHF 276'115', 'BRAIN-IT', '', ], [ 'CHF 200'000', 'Developing nanopore as a diagnostic device for detection of protein post-translational modifications', '', ], [ 'CHF 297'400', 'Identification of systemic immune cell-related biomarkers for early Alzheimer’s disease progression', '', ], [ 'CHF 298'553', 'Prediction of post-stroke cognitive decline and dementia: impact of cognitive reserve and post-stroke life style', '', ], [ 'CHF 200'000', 'Ultrastructure of Parkinson’s pathology in post-mortem human brain', '', ], [ 'CHF 300'000', 'Stabilization of native Tau as therapeutic approach for Alzheimer's disease', '', ], [ 'CHF 291'400', 'AD-Nets: Understanding Alzheimer’s phenotype at the level of large neuronal networks in tauopathy-associated dementia.', '', ], [ 'CHF 300'000', 'Astrocyte development and function in primary familial brain calcification', '', ], [ 'CHF 300'000', 'The role of astrocytic fatty acid b-oxidation in health and in Alzheimer’s disease', '', ], [ 'CHF 12'000', 'Test Project Zürich', '', ], [ 'CHF 15'000', 'Test Project Bern', '', ], [ 'CHF 20'000', 'Test Project St. Gallen', '', ], [ 'CHF 10'000', 'The Structure of Prionoid Tau Strains', '', ], [ 'CHF 1'000', 'Intrabodies to regulate Aβ production', '', ],
Anschrift

Stiftung Synapsis
Alzheimer Forschung Schweiz AFS
Josefstrasse 92
CH-8005 Zürich

So erreichen Sie uns

Spenderservice
Telefon: +41 (0)44 271 35 11
E-Mail: info(at)alzheimer-synapsis.ch

Spenden

Postfinance: 85-678574-7
IBAN: CH31 0900 0000 8567 8574 7 

Online-Spende